Company / Capital Returned to Shareholders
TG Therapeutics, Inc. Capital Returned to Shareholders History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$91.2M
FY2025
5-year range
$0 / $91.2M
FY2022-FY2025
Trend
+941.6%
vs FY2024
Sector context
#25 of 52
Health Care
What the data says
At $91M, TG Therapeutics, Inc.'s capital returned to shareholders ranks #25 of 52 in the Health Care sector. Improved from $0 to $91M over the past 2 years.
Based on SEC 10-K filings.
$91M in FY2025.
Improved from $0 to $91M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#25 of 52 in Health CareTop 48% of 52This company $91.2M Sector average $1.3B
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 941.6% year-over-year.
- Ranks #25 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $91.2M | +941.6% |
| FY2024 | $8.8M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026